9 Meters Biopharma, Inc. (NMTR)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
08-Jul-22 8:01 AM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 06-Jul-22Private Purchase 125,000$0.23$28,462.5010%
1.3M to 1.43M
06-Jul-22 4:43 PM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 01-Jul-22Private Purchase 175,000$0.25$42,962.5013%
1.3M to 1.48M
24-May-22 4:01 PM
View: 
Constantino Michael T.
Director
9 Meters Biopharma, Inc. (NMTR) 23-May-22Private Purchase 16,000$0.48$7,608.0036%
44.51K to 60.51K
19-May-22 4:09 PM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 18-May-22Private Purchase 50,000$0.45$22,285.004%
1.25M to 1.3M
19-May-22 4:01 PM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 18-May-22Private Purchase 106,383$0.47$50,000.008%
1.3M to 1.41M
07-Mar-22 8:01 AM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 03-Mar-22Private Purchase 86,450$0.58$50,002.407%
1.21M to 1.3M
04-Mar-22 8:00 AM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 03-Mar-22Private Purchase 100,000$0.56$55,590.009%
1.15M to 1.25M
03-Dec-21 7:34 AM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 02-Dec-21Market Purchase 50,000$0.89$44,500.004%
1.21M to 1.26M
6%
19-Nov-21 7:31 AM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 18-Nov-21Market Purchase 50,000$1.05$52,500.005%
1.1M to 1.15M
22-Nov-21 7:30 AM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 18-Nov-21Market Purchase 20,000$1.06$21,200.002%
1.19M to 1.21M
15-Sep-21 8:12 AM
View: 
Sitar Edward J
Chief Financial Officer
9 Meters Biopharma, Inc. (NMTR) 14-Sep-21Market Purchase 15,000$1.22$18,300.008%
179.34K to 194.34K
(< 1%)
08-Sep-21 8:15 AM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 07-Sep-21Market Purchase 73,529$1.36$99,999.407%
1.12M to 1.19M
(2%)
26-Aug-21 8:18 AM
View: 
Constantino Michael T.
Director
9 Meters Biopharma, Inc. (NMTR) 24-Aug-21Market Purchase 18,000$1.14$20,520.0053%
34.11K to 52.11K
8%
23-Aug-21 8:15 AM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 20-Aug-21Market Purchase 25,000$1.10$27,500.002%
1.1M to 1.12M
0%
19-Aug-21 8:16 AM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 18-Aug-21Market Purchase 25,000$1.05$26,250.002%
1.08M to 1.1M
25-Jun-21 7:08 PM
View: 
Orbimed Israel Gp Ltd.
10% Owner
9 Meters Biopharma, Inc. (NMTR) 25-Jun-21Market Sale 15,989,900$1.21$19,347,800.00(65%)
24.59M to 8.6M
25-Jun-21 7:08 PM
View: 
Orbimed Israel Gp Ltd.
10% Owner
9 Meters Biopharma, Inc. (NMTR) 24-Jun-21Market Sale 319,255$1.38$440,572.00(1%)
24.91M to 24.59M
25-Jun-21 7:08 PM
View: 
Orbimed Israel Gp Ltd.
10% Owner
9 Meters Biopharma, Inc. (NMTR) 23-Jun-21Market Sale 841,650$1.36$1,144,640.00(3%)
25.75M to 24.91M
13-May-21 6:34 PM
View: 
Orbimed Israel Gp Ltd.
10% Owner
9 Meters Biopharma, Inc. (NMTR) 11-May-21Exercise (in-the money or at-the-money) 31,944$0.65$20,836.40< 1%
51.45M to 51.48M
06-Apr-21 4:19 PM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 05-Apr-21Private Purchase 300,000$1.00$300,000.0038%
795.55K to 1.1M
(11%)
06-Apr-21 4:16 PM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 05-Apr-21Private Purchase 100,000$1.00$100,000.0010%
977.52K to 1.08M
(11%)
06-Apr-21 4:15 PM
View: 
Sitar Edward J
Chief Financial Officer
9 Meters Biopharma, Inc. (NMTR) 05-Apr-21Private Purchase 50,000$1.00$50,000.0039%
129.34K to 179.34K
(11%)
17-Dec-20 4:17 PM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 15-Dec-20Private Purchase 230,769$0.65$150,000.0041%
564.78K to 795.55K
17-Dec-20 4:17 PM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 15-Dec-20Private Purchase 153,846$0.65$99,999.9019%
823.68K to 977.52K
17-Dec-20 4:17 PM
View: 
Sitar Edward J
Chief Financial Officer
9 Meters Biopharma, Inc. (NMTR) 15-Dec-20Private Purchase 61,538$0.65$39,999.7091%
67.8K to 129.34K
01-Dec-20 4:10 PM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 27-Nov-20Grant 203,667----33%
620.01K to 823.68K
03-Nov-20 4:13 PM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 30-Oct-20Acquisition (other) 4,513----< 1%
615.5K to 620.01K
03-Nov-20 4:14 PM
View: 
Orbimed Israel Gp Ltd.
10% Owner
9 Meters Biopharma, Inc. (NMTR) 30-Oct-20Acquisition (other)
Duplicate
1,943,730----8%
23.77M to 25.72M
03-Nov-20 4:14 PM
View: 
Darvish Nissim
Director
10% Owner
9 Meters Biopharma, Inc. (NMTR) 30-Oct-20Acquisition (other) 1,943,730----8%
23.77M to 25.72M
03-Nov-20 4:14 PM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 30-Oct-20Acquisition (other) 4,513----< 1%
560.27K to 564.78K
14-Sep-20 8:06 AM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 11-Sep-20Market Purchase 77,000$0.68$52,360.0017%
461.78K to 538.78K
68%
14-Sep-20 8:06 AM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 11-Sep-20Market Purchase 21,485$0.65$14,003.904%
538.78K to 560.27K
75%
14-Sep-20 8:06 AM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 10-Sep-20Market Purchase 50,000$0.60$30,000.0012%
411.78K to 461.78K
92%
24-Aug-20 7:01 AM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 21-Aug-20Market Purchase 70,000$0.69$48,300.0013%
545.5K to 615.5K
69%
21-Aug-20 4:20 PM
View: 
Constantino Michael T.
Director
9 Meters Biopharma, Inc. (NMTR) 20-Aug-20Market Purchase 34,108$0.75$25,581.00100%
0 to 34.11K
55%
17-Aug-20 4:18 PM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 17-Aug-20Market Purchase 35,000$0.57$19,831.007%
510.5K to 545.5K
106%
18-Aug-20 5:19 PM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 17-Aug-20Market Purchase 100,000$0.56$56,000.0032%
311.78K to 411.78K
108%
02-Jul-20 4:26 PM
View: 
Sitar Edward J
Chief Financial Officer
9 Meters Biopharma, Inc. (NMTR) 30-Jun-20Conversion 67,800----100%
0 to 67.8K
02-Jul-20 4:25 PM
View: 
Orbimed Israel Gp Ltd.
10% Owner
9 Meters Biopharma, Inc. (NMTR) 30-Jun-20Conversion
Duplicate
6,786,500----40%
16.99M to 23.77M
02-Jul-20 4:22 PM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 30-Jun-20Conversion 271,400----114%
239.1K to 510.5K
02-Jul-20 4:24 PM
View: 
Darvish Nissim
Director
10% Owner
9 Meters Biopharma, Inc. (NMTR) 30-Jun-20Conversion 6,786,500----40%
16.99M to 23.77M
02-Jul-20 4:22 PM
View: 
Johnson Lorin K
Director
9 Meters Biopharma, Inc. (NMTR) 30-Jun-20Conversion 84,800----100%
0 to 84.8K
02-Jul-20 4:28 PM
View: 
Laumas Sandeep
Director
9 Meters Biopharma, Inc. (NMTR) 30-Jun-20Conversion 42,400----5%
776.37K to 818.77K
02-Jul-20 4:23 PM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 30-Jun-20Conversion 254,400----443%
57.38K to 311.78K
01-Jul-20 4:39 PM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 30-Jun-20Grant 189,655----384%
49.44K to 239.1K
16-Jun-20 4:05 PM
View: 
Sirgo Mark A
Director
9 Meters Biopharma, Inc. (NMTR) 15-Jun-20Market Purchase 17,943$0.60$10,720.9045%
39.44K to 57.38K
89%
15-Jun-20 4:56 PM
View: 
Temperato John
Chief Executive Officer
Director
9 Meters Biopharma, Inc. (NMTR) 15-Jun-20Market Purchase 10,000$0.60$5,971.0025%
39.44K to 49.44K
89%
01-Jul-19 5:00 PM
View: 
Laumas Sandeep
CEO, Executive Chairman
Director
9 Meters Biopharma, Inc. (NMTR) 28-Jun-19Market Purchase 4,000$1.15$4,600.00< 1%
772.37K to 776.37K
(5%)
17-Jun-19 8:03 PM
View: 
Laumas Sandeep
CEO, Executive Chairman
Director
9 Meters Biopharma, Inc. (NMTR) 13-Jun-19Market Purchase 1,000$1.22$1,215.91< 1%
771.37K to 772.37K
(11%)
03-Jun-19 8:00 AM
View: 
Madan Jay P.
President
Director
9 Meters Biopharma, Inc. (NMTR) 30-May-19Market Purchase 5,000$1.32$6,600.00< 1%
1.03M to 1.03M
(18%)